Visfatin in adipocytes is upregulated by hypoxia through HIF1α-dependent mechanism

Biochemical and Biophysical Research Communications

Volumn 349, Issue 3, 2006, Pages 875-882

  Segawa, Katsumori ^a   Fukuhara, Atsunori ^a   Hosogai, Naomi ^a   Morita, Kentaro ^a   Okuno, Yosuke ^a   Tanaka, Masaki ^a   Nakagawa, Yasuhiko ^a   Kihara, Shinji ^a   Funahashi, Tohru ^a   Komuro, Ryutaro ^a   Matsuda, Morihiro ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

HIF1 ; Hypoxia; Metabolic syndrome; Obesity; Visfatin

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; ADIPOCYTOKINE; COBALT CHLORIDE; DEFEROXAMINE; GLYCINE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN INHIBITOR; STABILIZING AGENT; UNCLASSIFIED DRUG; VISFATIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HYPOXIA; MOLECULAR DYNAMICS; MOLECULAR MIMICRY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL HYPOXIA; CYTOKINES; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MUTATION; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 33748596091     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.083     Document Type: Article

References (41)

1. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., Yamashita S., Miura M., Fukuda Y., Takemura K., Tokunaga K., and Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 2 (1996) 800-803
2. Matsuzawa Y., Funahashi T., and Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N Y Acad. Sci. 892 (1999) 146-154
3. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
4. Berg A.H., Combs T.P., and Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13 (2002) 84-89
5. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
6. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
7. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001) 941-946
8. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., and Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
9. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 184 (2005) 285-293
10. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., and Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
11. Samal B., Sun Y., Stearns G., Xie C., Suggs S., and McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell Biol. 14 (1994) 1431-1437
12. Brook C.G., Lloyd J.K., and Wolf O.H. Relation between age of onset of obesity and size and number of adipose cells. Br. Med. J. 2 (1972) 25-27
13. Helmlinger G., Yuan F., Dellian M., and Jain R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3 (1997) 177-182
14. Fleischmann E., Kurz A., Niedermayr M., Schebesta K., Kimberger O., Sessler D.I., Kabon B., and Prager G. Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes. Surg. 15 (2005) 813-819
15. Kabon B., Nagele A., Reddy D., Eagon C., Fleshman J.W., Sessler D.I., and Kurz A. Obesity decreases perioperative tissue oxygenation. Anesthesiology 100 (2004) 274-280
16. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.L., Bouloumie A., Barbatelli G., Cinti S., Svensson P.A., Barsh G.S., Zucker J.D., Basdevant A., Langin D., and Clement K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 (2005) 2277-2286
17. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12 (1992) 5447-5454
18. Liu Y., Cox S.R., Morita T., and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77 (1995) 638-643
19. Semenza G.L., Roth P.H., Fang H.M., and Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269 (1994) 23757-23763
20. Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., and Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271 (1996) 32529-32537
21. Firth J.D., Ebert B.L., Pugh C.W., and Ratcliffe P.J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. USA 91 (1994) 6496-6500
22. Semenza G.L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J. Clin. Invest. 106 (2000) 809-812
23. Wang G.L., Jiang B.H., Rue E.A., and Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92 (1995) 5510-5514
24. Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., Stumvoll M., and Bluher M. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
25. Hammarstedt A., Pihlajamaki J., Rotter Sopasakis V., Gogg S., Jansson P.A., Laakso M., and Smith U. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J. Clin. Endocrinol. Metab. 91 (2006) 1181-1184
26. Haider D.G., Schindler K., Schaller G., Prager G., Wolzt M., and Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J. Clin. Endocrinol. Metab. 91 (2006) 1578-1581
27. Lolmede K., Durand de Saint Front V., Galitzky J., Lafontan M., and Bouloumie A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 1187-1195
28. Rolfs A., Kvietikova I., Gassmann M., and Wenger R.H. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272 (1997) 20055-20062
29. Kimura H., Weisz A., Ogura T., Hitomi Y., Kurashima Y., Hashimoto K., D'Acquisto F., Makuuchi M., and Esumi H. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 276 (2001) 2292-2298
30. Di Girolamo M., Skinner Jr. N.S., Hanley H.G., and Sachs R.G. Relationship of adipose tissue blood flow to fat cell size and number. Am. J. Physiol. 220 (1971) 932-937
31. Digirolamo M., and Esposito J. Adipose tissue blood flow and cellularity in the growing rabbit. Am. J. Physiol. 229 (1975) 107-112
32. West D.B., Prinz W.A., Francendese A.A., and Greenwood M.R. Adipocyte blood flow is decreased in obese Zucker rats. Am. J. Physiol. 253 (1987) R228-R233
33. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., and Folkman M.J. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. USA 99 (2002) 10730-10735
34. Brakenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., and Cao Y. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 94 (2004) 1579-1588
35. Hermann C., Assmus B., Urbich C., Zeiher A.M., and Dimmeler S. Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 402-409
36. Hufton S.E., Moerkerk P.T., Brandwijk R., de Bruine A.P., Arends J.W., and Hoogenboom H.R. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett. 463 (1999) 77-82
37. Ye S.Q., Simon B.A., Maloney J.P., Zambelli-Weiner A., Gao L., Grant A., Easley R.B., McVerry B.J., Tuder R.M., Standiford T., Brower R.G., Barnes K.C., and Garcia J.G. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am. J. Respir. Crit. Care Med. 171 (2005) 361-370
38. Ebert B.L., Firth J.D., and Ratcliffe P.J. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J. Biol. Chem. 270 (1995) 29083-29089
39. Ak I., Stokkel M.P., and Pauwels E.K. Positron emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours. J. Cancer Res. Clin. Oncol. 126 (2000) 560-574
40. Higashi T., Tamaki N., Honda T., Torizuka T., Kimura T., Inokuma T., Ohshio G., Hosotani R., Imamura M., and Konishi J. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. J. Nucl. Med. 38 (1997) 1337-1344
41. Chen J., Zhao S., Nakada K., Kuge Y., Tamaki N., Okada F., Wang J., Shindo M., Higashino F., Takeda K., Asaka M., Katoh H., Sugiyama T., Hosokawa M., and Kobayashi M. Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am. J. Pathol. 162 (2003) 1283-1291